Dr. Reddys Laboratories (RDY)
(Real Time Quote from BATS)
$13.58 USD
+0.25 (1.88%)
Updated Aug 7, 2025 10:12 AM ET
3-Hold of 5 3
B Value D Growth C Momentum C VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
RDY 13.58 +0.25(1.88%)
Will RDY be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for RDY based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for RDY
Alvotech Gears Up to Report Q2 Earnings: Here's What to Expect
Dr. Reddy's Q1 Earnings Beat Estimates, Generics Sales Boost Revenues
RDY: What are Zacks experts saying now?
Zacks Private Portfolio Services
New Strong Sell Stocks for July 18th
Sage Therapeutics (SAGE) Soars 35.4%: Is Further Upside Left in the Stock?
Personalis (PSNL) Soars 7.3%: Is Further Upside Left in the Stock?
Other News for RDY
Dr. Reddy's: Needs To Invest $0.95 To Produce $1 Of New Revenues
SA Asks: Which stocks could be impacted by higher India tariffs?
Dr Reddy's Laboratories Ltd (RDY) Q1 2026 Earnings Call Highlights: Strong Revenue Growth ...
Wall Street Lunch: Return Of Meme Stock Frenzy Causes Volatility In The Market
Q1 2026 Dr Reddy's Laboratories Ltd Earnings Call Transcript